| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 30-Sep-08 | | Total Revenue | 60,085 | 59,966 | 56,278 | 108,075 | | Cost of Revenue | 41,613 | 41,279 | 39,397 | 69,080 | | | Gross Profit | 18,472 | 18,687 | 16,881 | 38,995 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,069 | 11,122 | 12,495 | 29,015 | | Non Recurring |
-
| 15,620 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,403 | (8,055) | 4,386 | 9,980 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (67) | 229 | (16) | 467 | | Earnings Before Interest And Taxes | 6,336 | (7,826) | 4,370 | 10,447 | | Interest Expense | 1,559 | 1,714 | 2,179 | 2,264 | | Income Before Tax | 4,777 | (9,540) | 2,191 | 8,183 | | Income Tax Expense | 1,909 | (3,851) | 855 | (22) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,868 | (5,689) | 1,336 | 8,205 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,868 | (5,689) | 1,336 | 8,205 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,868 | ($5,689) | $1,336 | $8,205 |
|
0.83% Nasdaq 
Income Statement
